In conclusion, blocking the binding of NCOA4 to FtMt, inactivating NCOA4, and reducing the stability of NCOA4 may protect cancer cells from ferroptosis by preventing ferritinophagy and maintaining the stored iron level. The gene discussed is NCOA4; the disease is cancer.